Allworth Financial’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Buy |
2,862
+1,323
| +86% | +$47.7K | ﹤0.01% | 1527 |
|
|
2025
Q1 | $49.3K | Buy |
1,539
+452
| +42% | +$14.5K | ﹤0.01% | 1550 |
|
|
2024
Q4 | $32.7K | Buy |
1,087
+877
| +418% | +$26.4K | ﹤0.01% | 1790 |
|
|
2024
Q3 | $5.93K | Buy |
210
+69
| +49% | +$1.95K | ﹤0.01% | 2493 |
|
|
2024
Q2 | $3.98K | Sell |
141
-1,531
| -92% | -$43.2K | ﹤0.01% | 2622 |
|
|
2024
Q1 | $50.8K | Sell |
1,672
-12
| -0.7% | -$364 | ﹤0.01% | 1301 |
|
|
2023
Q4 | $47.3K | Buy |
1,684
+731
| +77% | +$20.5K | ﹤0.01% | 1222 |
|
|
2023
Q3 | $25.9K | Buy |
953
+451
| +90% | +$12.2K | ﹤0.01% | 1378 |
|
|
2023
Q2 | $15.4K | Sell |
502
-17
| -3% | -$523 | ﹤0.01% | 1695 |
|
|
2023
Q1 | $18.7K | Buy |
519
+161
| +45% | +$5.8K | ﹤0.01% | 1489 |
|
|
2022
Q4 | $14.1K | Sell |
358
-27
| -7% | -$1.07K | ﹤0.01% | 1555 |
|
|
2022
Q3 | $15K | Sell |
385
-9
| -2% | -$351 | ﹤0.01% | 1419 |
|
|
2022
Q2 | $17K | Buy |
394
+382
| +3,183% | +$16.5K | ﹤0.01% | 1312 |
|
|
2022
Q1 | $0 | Buy |
+12
| New | – | ﹤0.01% | 2345 |
|